Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?

Critical Reviews in Immunology

Volumn 26, Issue 3, 2006, Pages 213-230

  Minas, Konstantinos ^a   Liversidge, Janet ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Allergy; Autoimmunity; Dendritic cells; Monocyte macrophage; Transplantation

Indexed keywords

ALLOANTIGEN; CD200FC FUSION PROTEIN; CHEMOKINE; CROSS REACTING ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GENE PRODUCT; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE GLYCOPROTEIN CD200; MEMBRANE GLYCOPROTEIN CD200 RECEPTOR; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD200R; PEPTIDE; PHOSPHATASE; PHOSPHOTRANSFERASE; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALLERGY; ALLOIMMUNITY; ALOPECIA; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTHRITIS; AUTOIMMUNITY; BONE MARROW CELL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTACT ALLERGY; CROSS BREEDING; CYTOKINE PRODUCTION; CYTOTOXIC LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; ENZYME ACTIVITY; EXPERIMENTAL RAT; FACIAL NERVE INJURY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HERPES VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VIVO STUDY; KERATINOCYTE; LEUKOCYTE MEMBRANE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; MAST CELL DEGRANULATION; MIXED LYMPHOCYTE REACTION; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MOLECULAR PHYLOGENY; MONONUCLEAR CELL; MOUSE STRAIN; NATURAL KILLER T CELL; NERVE TRANSECTION; NONHUMAN; OPEN READING FRAME; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR GENE; RECEPTOR UPREGULATION; RECOMBINANT DNA TECHNOLOGY; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SKIN GRAFT; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; UVEORETINITIS; WILD TYPE;

EID: 33746063259     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v26.i3.20     Document Type: Review

References (128)

1. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927-30.
2. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-79.
3. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 1998;280:243-48.
4. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35.
5. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
6. O'Garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000;10:542-50.
7. Nagy ZS, Ross J, Cheng H, Stepkowski SM, Kirken RA. Regulation of lymphoid cell apoptosis by Jaks and Stats. Crit Rev Immunol. 2004;24:87-110.
8. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science. 2000;290:84-9.
9. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol. 2005;23:901-44.
10. Lucas M, Daniel L, Tomasello E, Guia S, Horschowski N, Aoki N, Figarrella-Branger D, Gomez S, Vivier E. Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur J Immunol. 2002;32:2653-63.
11. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3:445-53.
12. Oldenborg PA. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma 2004;45:1319-27.
13. Barclay AN, Wright GJ, Brooke G, Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 2002;23:285-90.
14. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol. 2005;6:579-86.
15. Kubagawa H, Chen CC, Ho LH, Shimada TS, Gartland L, Mashburn C, Uehara T, Ravetch JV, Cooper MD. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med. 1999;189:309-18.
16. Blery M, Kubagawa H, Chen CC, Vely F, Cooper MD, Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A. 1998;95:2446-51.
17. Maeda A, Kurosaki M, Kurosaki T. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor gamma chain. J Exp Med. 1998;188:991-95.
18. Samaridis J, Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol. 1997;27:660-65.
19. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med. 1997;185:1743-51.
20. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 1997;386:181-6.
21. Dietrich J, Cella M, Seiffert M, Buhring HJ, Colonna M. Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol. 2000;164:9-12.
22. Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001;11:130-5.
23. Anderton S, Burkhart C, Metzler B, Wraith D. Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis. Immunol Rev. 1999;169:123-37.
24. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity. 2001;14:145-55.
25. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005;175:342-49.
26. Stout RD, Suttles J. T cell signaling of macrophage function in inflammatory disease. Front Biosci. 1997;2:197-206.
27. Barclay AN, Ward HA. Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2. Eur J Biochem. 1982;129:447-58.
28. McMaster WR, Williams AF. Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol Rev. 1979;47:117-37.
29. Webb M, Barclay AN. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J Neurochem. 1984;43:1061-7.
30. Dick AD, Broderick C, Forrester JV, Wright GJ. Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci. 2001;42:170-6.
31. Bukovsky A, Presl J, Zidovsky J. Association of some cell surface antigens of lymphoid cells and cell surface differentiation antigens with early rat pregnancy. Immunology. 1984;52:631-40.
32. Wright GJ, Jones M, Puklavec MJ, Brown MH, Barclay AN. The unusual distribution of the neuronal/ lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology. 2001;102:173-9.
33. Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol. 2004;123(5):880-7.
34. Williams AF, Gagnon J. Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science. 1982;216:696-703.
35. Clark MJ, Gagnon J, Williams AF, Barclay AN. MRC OX-2 antigen: a lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobulin light chain. EMBO J. 1985;4:113-18.
36. Preston S, Wright GJ, Starr K, Barclay AN, Brown MH. The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur J Immunol. 1997;27:1911-8.
37. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH, Barclay AN. Lymphoid/ neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity. 2000;13:233-42.
38. Borriello F, Tizard R, Rue E, Reeves R. Characterization and localization of Mox2, the gene encoding the murine homolog of the rat MRC OX-2 membrane glycoprotein. Mamm Genome. 1998;9:114-8.
39. Gaglia JL, Mattoo A, Greenfield EA, Freeman GJ, Kuchroo VK. Characterization of endogenous Chinese hamster ovary cell surface molecules that mediate T cell costimulation. Cell Immunol. 2001;213:83-93.
40. Gorczynski RM, Chen Z, Fu XM, Zeng H. Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival. Transplantation. 1998;65:1106-14.
41. Gorczynski RM, Cattral MS, Chen Z, Hu J, Lei J, Min WP, Yu G, Ni J. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol. 1999;163:1654-60.
42. Gorczynski RM, Chen Z, Kai Y, Lei J. Evidence for persistent expression of OX2 as a necessary component of prolonged renal allograft survival following portal vein immunization. Clin Immunol 2000;97:69-78.
43. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000;290:1768-71.
44. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T. The mononuclear phagocyte system revisited. J Leukoc Biol. 2002;72:621-7.
45. Kraal G, Janse M. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology. 1986;58:665-9.
46. Lanier LL, Bakker AB. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today. 2000;21:611-4.
47. Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, Moqrich A, Gautheret D, Djabali M, Mattei MG, Vivier E. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 1998;273:34115-9.
48. Tomasello E, Cant C, Buhring HJ, Vely F, Andre P, Seiffert M, Ullrich A, Vivier E. Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol. 2000;30:2147-56.
49. Preston S, Wright GJ, Starr K, Barclay AN, Brown MH. The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur J Immunol. 1997;27:1911-8.
50. Graeber MB, Lopez-Redondo F, Ikoma E, Ishikawa M, Imai Y, Nakajima K, Kreutzberg GW, Kohsaka S. The microglia/macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res. 1998;813:241-53.
51. Bakker AB, Hoek RM, Cerwenka A, Blom B, Lucian L, McNeil T, Murray R, Phillips LH, Sedgwick JD, Lanier LL. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. 2000;13:345-53.
52. Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol. 2000;30:1568-75.
53. Taylor N, McConachie K, Calder C, Dawson R, Dick A, Sedgwick JD, Liversidge J. Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge. J Immunol. 2005;174:143-54.
54. Jenmalm MC, Cherwinski H, Bowman EP, Phillips J, Sedgwick JD. Regulation of myeloid cell function through the CD200 receptor. J Immunol. 2006;176:191-9.
55. Robertson M, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD. Retinal micro-environment determines both resident and infiltrating macrophage function during experimental autoimmune uveoretinitis (EAU). Invest Ophthalmol Vis Sci. 2002;44:3034-41.
56. Broderick C, Hoek R.M., Forrester J.V., Liversidge J, Sedgwick J, Dick AD. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol. 2002;161:1669-77.
57. Carter DA, Dick AD. CD200 maintains microglial potential to migrate in adult human retinal explant model. Curr Eye Res. 2004;28:427-36.
58. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T,Liu MR, Brown MH, Sedgwick JD, Phillips JH, Barclay AN . Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003;171:3034-46.
59. Gorczynski RM, Chen Z, Clark DA, Kai Y, Lee L, Nachman J, Wong S, Marsden P. Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface. Am J Reprod Immunol. 2004;52:147-63.
60. Gorczynski R, Chen Z, Kai (2 Y, Lee L, Wong S, Marsden PA. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol. 2004;172:7744-9.
61. Hatherley D, Cherwinski HM, Moshref M, Barclay AN. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor. J Immunol. 2005;175:2469-74.
62. Vieites JM, de la TR, Ortega MA, Montero T, Peco JM, Sanchez-Pozo A, Gil A, Suarez A. Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13. Gene. 2003;311:99-104.
63. van der Merwe PA, Barclay AN. Analysis of cell-adhesion molecule interactions using surface plasmon resonance. Curr Opin Immunol. 1996;8:257-61.
64. van der Merwe PA, Brown MH, Davis SJ, Barclay AN. Measuring very low affinity interactions between immunoglobulin superfamily cell-adhesion molecules. Biochem Soc Trans. 1993;21:340S.
65. Zhang S, Cherwinski H, Sedgwick JD, Phillips JH. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol. 2004;173:6786-93.
66. Hatherley D, Barclay AN. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur J Immunol. 2004;34:1688-94.
67. Chen DX, He H, Gorczynski RM. Synthetic peptides from the N-terminal regions of CD200 and CD200R1 modulate immunosuppressive and anti-inflammatory effects of CD200-CD200R1 interaction. Int Immunol. 2005;17:289-96.
68. Gorczynski RM. Transplant tolerance modifying antibody to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages. Eur J Immunol. 2001;31:2331-7.
69. Voehringer D, Rosen DB, Lanier LL, Locksley RM. CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells. J Biol Chem. 2004;279:54117-23.
70. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875-904.
71. Veillette A, Latour S, Davidson D. Negative regulation of immunoreceptor signaling. Annu Rev Immunol. 2002;20:669-707.
72. Seiffert M, Brossart P, Cant C, Cella M, Colonna M, Brugger W, Kanz L, Ullrich A, Buhring HJ. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+) CD38(-) hematopoietic cells. Blood. 2001;97:2741-9.
73. Barclay AN, Birkeland ML, Brown MH, Beyers AD, D avis, SJ, Somoza C, Williams AF. Leukocyte antigens factsbook. London: Academic Press; 2005.
74. Barclay AN. Membrane proteins with immunoglobulin-like domains - a master superfamily of interaction molecules. Semin Immunol. 2003;15:215-23.
75. Williams AF, Barclay AN. The immunoglobulin superfamily - domains for cell surface recognition. Annu Rev Immunol. 1988;6:381-405.
76. Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol. 2004;78:7667-76.
77. Shiratori I, Yamaguchi M, Suzukawa M, Yamamoto K, Lanier LL, Saito T, Arase H. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J Immunol. 2005;175:4441-9.
78. Cameron CM, Barrett JW, Liu L, Lucas AR, McFadden G. Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J Virol. 2005;79:6052-67.
79. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323-6.
80. Gorczynski RM, Yu K, Clark D. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity In vitro and In vivo [In Process Citation]. J Immunol. 2000;165:4854-60.
81. Cherwinski HM, Murphy CA, Joyce BL, Bigler ME, Song YS, Zurawski SM, Moshrefi MM, Gorman DM, Miller KL, Zhang S,Sedgwick JD, Phillips JH. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J Immunol. 2005;174:1348-56.
82. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749-86.
83. Banerjee D, Dick AD. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul Immunol Inflamm. 2004;12:115-25.
84. Gorczynski RM, Chen Z, Lee L, Yu K, Hu J. Anti-CD200R ameliorates collagen-induced arthritis in mice. Clin Immunol. 2002;104:256-64.
85. Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Truitt RL. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood. 2004;103:2691-8.
86. Dick A, Broderick C, Forrester JV, Liversidge J, Hoek R, Sedgwick J. CD200 regulation of myeloid cell activation and distribution during experimental autoimmune uveoretinitis. J Neuroimmunol. 2001;118:27.
87. Dick AD, Cheng YF, Liversidge J, Forrester JV. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology. 1994;82:625-31.
88. Dick AD, Sharma V, Liversidge J. Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy. Br J Ophthalmol. 2001;85:1001-6.
89. Chang HC, Zhang S, Kaplan MH. Neonatal tolerance in the absence of Stat4- and Stat6-dependent Th cell differentiation. J Immunol. 2002;169:4124-8.
90. Nakamura T, Terajewicz A, Stein-Streilein J. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol. 2005;175:2643-6.
91. Grunig G, Banz A, de Waal MR. Molecular regulation of Th2 immunity by dendritic cells. Pharmacol Ther. 2005;106:75-96.
92. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol. 1999;21:339-59.
93. Dallman MJ. Cytokines and transplantation: Th1/ Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol. 1995;7:632-8.
94. Li XC, Zand MS, Li Y, Zheng XX, Strom TB. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol. 1998;161:2241-7.
95. Gorczynski RM, Chen Z, Fu XM, Levy G, Cohen Z. Gamma delta TCR+ cells regulate rejection of small intestinal allografts in rats. Transplant Proc. 1997;29:863-4.
96. Mincheva-Nilsson L. Pregnancy and gamma/delta T cells: taking on the hard questions. Reprod Biol Endocrinol. 2003;1:120.
97. Imamura M, Tanaka J. Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect. Int J Hematol. 2003;78:188-94.
98. Clark DA. Hard science versus phenomenology in reproductive immunology. Crit Rev Immunol. 1999;19:509-39.
99. Starzl TE, Rao AS, Thomson AW, Murase N, Demetris AJ. Donor-recipient microchimerism and tolerance induction. Transplantation. 1996;61:169-72.
100. Chung SW, Yoshida EM, Cattral MS, Hu Y, Gorczynski RM. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett. 1998;63:91-6.
101. Koga S, Luke PP, Specht SM, Rominski B, Jaquins-Gerstl A, Hoffman RA, Thomson AW, Jordan ML. Inhibition of the allograft response by donor specific blood transfusion: association with reduced local TH1 cytokines and nitric oxide but enhanced prostaglandin E2 production. Transplantation. 2000;70:1788-96.
102. Ghanekar A, Mendicino M, Liu H, He W, Liu M, Zhong R, Phillips MJ, Levy GA, Grant DR. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol. 2004;172:5693-701.
103. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J Immunol. 1998;160:545-9.
104. Gorczynski RM, Yu K, Clark D. Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo. J Immunol. 2000;165:4854-60.
105. Gorczynski RM, Chen Z, Kai Y, Wong S, Lee L. Induction of tolerance-inducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R. Transplantation. 2004;77:1138-44.
106. Yu K, Chen Z, Wang S, Gorczynski R. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter. Transplantation. 2005;80:394-401.
107. Gorczynski RM, Lee L, Boudakov I. Augmented induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R. Transplantation. 2005;79:1180-3.
108. Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am J Reprod Immunol. 2003;49:297-307.
109. Gorczynski RM, Chen Z, Clark DA, Hu J, Yu G, Li X, Tsang W, Hadidi S. Regulation of gene expression of murine MD-1 regulates subsequent T cell activation and cytokine production. J Immunol. 2000;165:1925-32.
110. Hadidi S, Gorczynski RM. MD-1 expression regulates direct and indirect allorecognition. Tissue Antigens. 2004;63:132-41.
111. Zhang X, Chen BC, Xiang FL, Chang S, Zhou HM, Du DF, Yuan J, Chen ZK. Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice. Transplant Proc. 2005;37:1965-7.
112. Gorczynski RM, Hadidi S, Yu G, Clark DA. The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol. 2002;48:18-26.
113. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000;191:411-16.
114. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685-711.
115. Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol. 2005;17:583-8.
116. Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999;189:877-82.
117. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004;114:280-90.
118. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762-74.
119. Grohmann U, Bianchi R, Orabona C, Fallarino F, Vacca C, Micheletti A, Fioretti MC, Puccetti P. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J Immunol. 2003;171:2581-7.
120. Grohmann U, Fallarino F, Bianchi R, Belladonna ML, Vacca C, Orabona C, Uyttenhove C, Fioretti MC, Puccetti P. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol. 2001;167:708-14.
121. Mellor AL, Baban B, Chandler P, Marshall B, Jhaver K, Hansen A.Koni PA, Iwashima M, Munn DH. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol. 2003;171:1652-5.
122. Bauer TM, Jiga LP, Chuang JJ, Randazzo M, Opelz G, Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int. 2005;18:95-100.
123. Bozza S, Fallarino F, Pitzurra L, Zelante T, Montagnoli C, Bellocchio S, Mosci P, Vacca C, Puccetti P, Mellor AL. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol. 2005;174:2910-8.
124. Funeshima N, Fujino M, Kitazawa Y, Hara Y, Hara Y, Hayakawa K, Okuyama T, Kimura H, Li XK. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase. J Gene Med. 2005;7:565-75.
125. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown B, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191-3.
126. Fallarino F, Asselin-Paturel C, Vacca C, Bianchi R, Gizzi S, Fioretti MC, Trinchieri G, Grohmann U, Puccetti P. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol. 2004;173:3748-54.
127. Fallarino F, Orabona C, Vacca C, Bianchi R, Gizzi S, Asselin-Paturel, Fioretti MC, Trinchieri G, Grohmann U, Puccetti P. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabol ism in plasmacytoid dendritic cells. Int Immunol. 2005;17:1429-38.
128. Dick AD, Forrester JV, Liversidge J, Cope AP. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res. 2004;23:617-37.